Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

Schizophrenia Research

Volumn 116, Issue 2-3, 2010, Pages 243-251

  Rojo, Emilio ^a   Pino, Oscar ^a   Guilera, Georgina ^b   Gómez Benito, Juana ^b   Purdon, Scot E ^c   Crespo Facorro, Benedicto ^d   Cuesta, Manuel J ^e   Franco, Manuel ^f   Martínez Arán, Anabel ^g   Segarra, Nuria ^b   Tabarés Seisdedos, Rafael ^h   Vieta, Eduard ^g   Bernardo, Miguel ^b   Mesa, Francisco ⁱ   Rejas, Javier ⁱ  

^a HOSPITAL GENERAL DE CATALUNYA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f Hospital General de Zamora   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h UNIVERSITY OF VALENCIA   (Spain)

ⁱ PFIZER INC   (United States)

Author keywords

Bipolar disorder; Cognitive impairment; Cut off scores; Schizophrenia; SCIP; Screening

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REFERENCE VALUE; SCHIZOPHRENIA; SCORING SYSTEM; SCREEN FOR COGNITIVE IMPAIRMENT IN PSYCHIATRY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

ADULT; BIPOLAR DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 74849124926     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.08.005     Document Type: Article

References (49)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR) (2000), APA, Washington DC
2. Andreasen N.C., Flaum M., and Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49 (1992) 615-623
3. Army Individual Test Battery. Manual of directions and scoring (1944), War Department, Adjutant General ́s Office, Washington, DC
4. Czobor P., Jaeger J., Berns S.M., Gonzalez C., and Loftus S. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia. Bipolar Disord. 9 1-2 (2007) 71-92
5. Dickinson D., Bellack A.S., and Gold J.M. Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophr. Bull. 33 (2007) 1213-1220
6. Duff K., Humphreys-Clark J.D., O'Bryant S.E., Mold J.W., Schiffer R.B., and Sutker P.B. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers. Arch. Clin. Neuropsychol. 23 (2008) 603-612
7. Eisenstein N., Engelhart C.I., Johnson V., Wolf J., Williamson J., and Losonczy M.B. Normative data for healthy elderly persons with the neurobehavioral cognitive status exam (Cognistat). Appl. Neuropsychol. 9 (2002) 110-113
8. Engelhart C., Eisenstein N., Johnson V., Wolf J., Williamson J., Steitz D., Girard V., Paramatmuni K., Ouzounian N., Losonczy M., and Estes W.K. Factor structure of the Neurobehavioral Cognitive Status Exam (COGNISTAT) in healthy, and psychiatrically and neurologically impaired, elderly adults. Clin. Neuropsychol. 13 (1999) 109-111
9. Estes W.K. Learning theory and intelligence. Am. Psychol. 29 (1974) 740-749
10. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psych. Res. 12 (1975) 189-198
11. Garcia C., Leahy B., Corradi K., and Forchetti C. Component structure of the repeatable battery for the assessment of neuropsychological status in dementia. Arch. Clin. Neuropsychol. 23 (2008) 63-72
12. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 153 (1996) 321-330
13. Green M.F., and Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 72 (2004) 1-3
14. Guilera G., Pino O., Gómez-Benito J., Rojo J.E., Vieta E., Tabarés-Seisdedos R., Segarra N., Martínez-Arán A., Franco M., Cuesta M.J., Crespo-Facorro B., Bernardo M., Purdon S.E., Díez T., Rejas J., and on behalf of the Spanish Working Group in Cognitive Function. Clinical usefulness of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual. Life Outcomes 7 28 (2009) 10.1186/1477-7525-7-28
15. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
16. Harvey P.D., and Sharma T. Understanding and Treating Cognition in Schizophrenia (2002), Ed Martin Dunitz, United Kingdom
17. Harvey P.D., Bowie C.R., and Loebel A. Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. J. Neuropsychiatry Clin. Neurosci. 18 (2006) 54-63
18. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 (1998) 426-445
19. Hill S.K., Sweeney J.A., Hamer R.M., Keefe R.S., Perkins D.O., Gu H., McEvoy J.P., and Lieberman J.A. Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia. J. Int. Neuropsychol. Soc. 14 (2008) 209-221
20. Hobart M.P., Goldberg R., Bartko J.J., and Gold J.M. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. Am. J. Psychiatry 156 (1999) 1951-1957
21. Jaeschke R., Guyatt G.H., and Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?. JAMA 271 (1994) 703-707
22. Kay S.R., Opler L.A., and Fiszbein A. The Positive and Negative Syndrome Scale (PANSS). Rat. Man. Soc. Behav. Sci. Doc. 17 (1986) 28-29
23. Keefe R.S. Should cognitive impairment be included in the diagnostic criteria for schizophrenia?. World Psychiatry 7 1 (2008) 22-28
24. Keefe R.S., Harvey P.D., Goldberg T.E., Gold J.M., Walker T.M., Kennel C., and Hawkins K. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr. Res. 102 (2008) 108-115
25. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., and Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 68 (2004) 283-297
26. Kéri S., and Janka Z. Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Acta Psychiatr. Scand. 110 (2004) 83-91
27. Kern R.S., Green M.F., Nuechterlein K.H., and Deng B.H. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr. Res. 72 (2004) 9-11
28. Kiernan R.J., Mueller J., Langston J.W., and Van Dyke C. The neurobehavioral cognitive status examination: a brief but quantitative approach to cognitive assessment. Ann. Intern. Med. 107 (1987) 481-485
29. Lewis R. Should cognitive deficit be a diagnostic criterion for schizophrenia?. J. Psychiatry Neurosci. 29 2 (2004) 102-113
30. Martino D.J., Marengo E., Igoa A., Scápola M., Ais E.D., Perinot L., and Strejilevich S.A. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: A prospective 1 year follow-up study. J. Affect. Disord. 116 (2009) 37-42
31. Metz C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 8 (1978) 283-298
32. Nøkleby K., Boland E., Bergersen H., Schanke A.K., Farner L., Wagle J., and Wyller T.B. Screening for cognitive deficits after stroke: a comparison of three screening tools. Clin. Rehabil. 22 (2008) 1095-1104
33. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., and Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72 (2004) 29-39
34. Peralta V., and Cuesta M.J. Escala del síndrome positivo y negativo en la esquizofrenia (PANSS). Manual de puntuación (2004)
35. Pino O., Guilera G., Gómez J., Rojo E., Vallejo J., and Purdon S.E. Escala breve para evaluar la afectación cognitiva en pacientes psiquiátricos [A brief scale to assess cognitive impairment in psychiatric patients]. Psicothema 18 (2006) 447-452
36. Pino O., Guilera G., Rojo E., Gómez-Benito J., Bernardo M., Crespo-Facorro, Cuestas M.J., Franco M., Martinez-Arán, Segarra N., Tabarés-Seisdedos R., Vieta E., Purdon S.E., Díez T., Rejas J., and the Spanish Working Group in Cognitive Function. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophr. Res. 99 (2008) 139-148
37. Purdon S.E. The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternate forms (2005), PNL Inc, Edmonton, Alberta
38. Randolph C., Tierney M.C., Mohr E., and Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20 (1998) 310-319
39. Rosen W.G. Verbal fluency in aging and dementia. J. Clin. Neuropsychol. 2 (1980) 135-146
40. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., and Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 51 (1994) 124-131
41. Tabarés-Seisdedos R., Balanzá-Martínez V., Sánchez-Moreno J., Martinez-Aran A., Salazar-Fraile J., Selva-Vera G., Rubio C., Mata I., Gómez-Beneyto M., and Vieta E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J. Affect. Disord. 109 (2008) 286-299
42. Taylor M.J., and Heaton R.K. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J. Int. Neuropsychol. Soc. 7 (2001) 867-874
43. Thompson J.M., Gallagher P., Hughes J.H., Watson S., Gray J.M., Ferrier I.N., and Young A.H. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br. J. Psychiatry 186 (2005) 32-40
44. Velligan D.I., DiCocco M., Bow-Thomas C.C., Cadle C., Glahn D.C., Miller A.L., Biggs M.M., Shores-Wilson K., McKenzie C.A., and Crismon M.L. A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophr. Res. 71 (2004) 273-283
45. Wechsler D. Wechsler Adults Intelligence Scale 3, WAIS-III manual (1999), TEA Ediciones, Madrid Spanish version
46. Wechsler D. Wechsler Memory Scale 3, WMS-III manual (2004), TEA Ediciones, Madrid Spanish version
47. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., and Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch. Gen. Psychiatry 57 (2000) 907-913
48. Wilk C.M., Gold J.M., Bartko J.J., Dickerson F., Fenton W.S., Knable M., Randolph C., and Buchanan R.W. Test-retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia. Am. J. Psychiatry 159 (2002) 838-844
49. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435